Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

PDL BioPharma Inc (NASDAQ:PDLI)

2.54
Delayed Data
As of 4:14pm ET
 +0.08 / +3.25%
Today’s Change
1.93
Today|||52-Week Range
3.77
+19.81%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Mclaughlin John Peter
President & Chief Executive Officer
Gift3/04/2017588,235$2.04$1.2M+15.49%
Stone Christopher Lewis
General Counsel, Secretary & Vice President
Gift3/04/2017214,372$2.04$437.3K+15.49%
Garcia Peter S
Chief Financial Officer & Vice President
Gift3/04/2017212,669$2.04$433.8K+15.49%
Hart Danny J Jr
Vice President-Business Development
Gift3/04/2017199,019$2.04$406.0K+15.49%
Pietzke Steffen
Chief Accounting Officer & Controller
Gift3/04/201798,039$2.04$200.0K+15.49%
Gryska David W
Director
Gift6/09/201760,729$2.47$150.0K-0.40%
Lindell Jody S
Director
Gift6/09/201760,729$2.47$150.0K-0.40%
Edick Paul R
Director
Gift6/09/201760,729$2.47$150.0K-0.40%
Saks Samuel R
Director
Gift6/09/201760,729$2.47$150.0K-0.40%
Sandman Paul W
Director
Gift6/09/201760,729$2.47$150.0K-0.40%
Page of 3